What’s a SPAC – and why might investors looking to get in early on the next hot biotech stocks want to consider investing in one? As today’s article explains, a SPAC (special purpose acquisition company) “is a publicly traded shell company that raises capital with the intent of acquiring a private business. SPACs have become an intriguing alternative for companies that want to go public because they allow that to happen much faster than with an initial public offering (IPO).” With SPACs gaining in popularity, the author highlights the newest biotech SPAC on the scene – and the man who could lead it to massive returns. CLICK HERE.
The New Biotech SPAC On The Scene – And The Man Who Could Lead It To Massive Returns
- by Bob Mitchell